We are live on
!
Find out more
KBG
Kahn Brothers Group Portfolio holdings
AUM
$564M
1-Year Est. Return
25.3%
This Fund
S&P 500
This Quarter
Est. Return
+17.16%
1 Year Est. Return
+25.3%
3 Year Est. Return
+38.07%
5 Year Est. Return
+72.96%
10 Year Est. Return
+308.37%
AUM
$640M
AUM Growth
+$85.4M
(+15%)
Cap. Flow
-$15.5M
Cap. Flow
% of AUM
-2.43%
Top 10 Holdings %
Top 10 Hldgs %
76.22%
Holding
32
New
1
Increased
3
Reduced
24
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$24.1M |
| 2 |
Patterson-UTI
PTEN
|
+$1.33M |
| 3 |
GSK
GSK
|
+$624K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
New York Times
NYT
|
+$16.5M |
| 2 |
HOLX
Hologic
HOLX
|
+$9.46M |
| 3 |
Merck
MRK
|
+$3.71M |
| 4 |
STL
Sterling Bancorp
STL
|
+$2.8M |
| 5 |
BP
BP
|
+$2.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.44% |
| 2 | Healthcare | 29.35% |
| 3 | Energy | 13.44% |
| 4 | Technology | 9.78% |
| 5 | Consumer Staples | 4.9% |
Similar funds
AHSW
LC
PSC
TCP
OC
KF
AAS
PEP
Kahn Brothers Group's Q1 2019 Portfolio in Review
As of Q1 2019, Kahn Brothers Group held 32 positions worth $640M, up 15% from $555M the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Trading was light in Q1 2019: portfolio turnover was 3.1%. Kahn Brothers Group opened 1 new position and made no exits, leaving the 32-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Energy.
- Kahn Brothers Group added most to Bristol-Myers Squibb in Q1 2019, an estimated $24.1M increase.
- Kahn Brothers Group's biggest Q1 2019 reduction was New York Times, cutting an estimated $16.5M.
- Kahn Brothers Group's ten largest holdings make up 76% of its $640M portfolio in Q1 2019.
- Kahn Brothers Group opened 1 new position and closed 0 in Q1 2019.
- Kahn Brothers Group's portfolio value rose 15% quarter-over-quarter to $640M.
Based on Kahn Brothers Group's 13F filing for Q1 2019, filed 6 May 2019.